8
Views
43
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate

, , , , &
Pages 6240-6252 | Received 09 Nov 1998, Accepted 07 Jun 1999, Published online: 27 Mar 2023

REFERENCES

  • Andreasen, P. A., L. Kjoller, L. Christensen, and J. Duffy 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1–22.
  • Angel, P., and J. Karin 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129–157.
  • Baumann, H., K. K. Morella, and J. Wong 1993. TNF-alpha, IL-1 beta, and hepatocyte growth factor cooperate in stimulating specific acute phase plasma protein genes in rat hepatoma cells. J. Immunol. 151:4248–4257.
  • Berthelsen, J., J. Vandekerkhove, and J. Blasi 1996. Purification and characterization of UEF3, a novel factor involved in the regulation of the urokinase and other AP-1 controlled promoters. J. Biol. Chem. 271:3822–3830.
  • Besser, D., M. Presta, and J. Nagamine 1995. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6:1009–1107.
  • Besser, D., M. Urich, M. Sakaue, A. Messerschmitt, K. Ballmer-Hofer, and J. Nagamine 1995. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen. Oncogene 11:2383–2391.
  • Besser, D., P. Verde, Y. Nagamine, and J. Blasi 1996. Signal transduction and the uPA/uPAR system. Fibrinolysis 10:215–237.
  • Bird, T. A., J. M. Kyriakis, L. Tyshler, M. Gayle, A. Milne, and J. Virca 1994. Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J. Biol. Chem. 269:31836–31844.
  • Blasi, F. 1993. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105–111.
  • Blasi, F., and J. Verde 1990. Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1:117–126.
  • Bruder, J. T., G. Heidecker, and J. Rapp 1992. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6:545–556.
  • Busso, N., E. Nicodeme, C. Chesne, A. Guillouzo, D. Belin, and J. Hyafil 1994. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 20:186–190.
  • Campbell, I. K., D. S. Piccoli, D. M. Butler, D. K. Singleton, and J. Hamilton 1988. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim. Biophys. Acta 967:183–194.
  • Cano, E., C. A. Hazzalin, and J. Mahadevan 1994. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol. 14:7352–7362.
  • Chomczynski, P., and J. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
  • De Cesare, D., M. Palazzolo, J. Berthelsen, and J. Blasi 1997. Characterization of UEF-4, a DNA-binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer. J. Biol. Chem. 272:23921–23929.
  • De Cesare, D., M. Palazzolo, and J. Blasi 1996. Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. Oncogene 13:2551–2562.
  • De Cesare, D., D. Vallone, A. Caracciolo, P. Sassone-Corsi, C. Nerlov, and J. Verde 1995. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11:365–376.
  • Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and J. Davis 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037.
  • D’Orazio, D., D. Besser, R. Marksitzer, C. Kunz, D. A. Hume, B. Kiefer, and J. Nagamine 1997. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201:179–187.
  • El-Shemerly, M. Y., D. Besser, M. Nagasawa, and J. Nagamine 1997. 12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J. Biol. Chem. 272:30599–30602.
  • Fowles, L. F., M. L. Martin, L. Nelsen, K. J. Stacey, D. Redd, Y. M. Clark, Y. Nagamine, M. McMahon, D. A. Hume, and J. Ostrowski 1998. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18:5148–5156.
  • Galang, C. K., C. J. Der, and J. Hauser 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9:2913–2921.
  • Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard, and J. Davis 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:2760–2770.
  • Gupta, S., D. Campbell, B. Derijard, and J. Davis 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389–393.
  • Gutman, A., and J. Wasylyk 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the Pea3 and AP-1 binding sites. EMBO J. 9:2241–2246.
  • Gutman, A., and J. Wasylyk 1991. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 7:49–54.
  • Irigoyen, J. P., D. Besser, and J. Nagamine 1997. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway. J. Biol. Chem. 272:1904–1909.
  • Kallunki, T., T. Deng, M. Hibi, and J. Karin 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87:929–939.
  • Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483–16486.
  • Kawasaki, H., J. Song, R. Eckner, H. Ugai, R. Chiu, K. Taira, Y. Shi, N. Jones, and J. Yokoyama 1998. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12:233–245.
  • Kim, T. H., W. M. Mars, D. B. Stolz, B. E. Petersen, and J. Michalopoulos 1997. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 26:896–904.
  • Kortenjann, M., O. Thomae, and J. Shaw 1994. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol. Cell. Biol. 14:4815–4824.
  • Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and J. Ostrowski 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355–5362.
  • Lengyel, E., B. Singh, R. Gum, C. Nerlov, A. Sabichi, M. Birrer, and J. Boyd 1995. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene. Oncogene 11:2639–2648.
  • Lengyel, E., E. Stepp, R. Gum, and J. Boyd 1995. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J. Biol. Chem. 270:23007–23012.
  • Livingstone, C., G. Patel, and J. Jones 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1785–1797.
  • Logan, S. K., M. J. Garabedian, C. E. Campbell, and J. Werb 1996. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271:774–782.
  • Mahadevan, L. C., and J. Edwards 1991. Signalling and superinduction. Nature 349:747–748 (Letter.)
  • Majka, S. M., and J. McGuire 1997. Regulation of urokinase expression in the developing avian heart: a role for the Ets-2 transcription factor. Mech. Dev. 68:127–137.
  • Marshall, B. C., Q. P. Xu, N. V. Rao, B. R. Brown, and J. Hoidal 1992. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J. Biol. Chem. 267:11462–11469.
  • Miralles, F., M. Parra, C. Caelles, Y. Nagamine, J. Felez, and J. Munoz-Canoves 1998. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol. Cell. Biol. 18:4537–4547.
  • Naldini, L., L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, W. Birchmeier, Y. Daikuhara, H. Tsubouchi, F. Blasi, and J. Comoglio 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:4825–4833.
  • Nerlov, C., D. De Cesare, F. Pergola, A. Caracciolo, F. Blasi, M. Johnsen, and J. Verde 1992. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J. 11:4573–4582.
  • Nerlov, C., P. Rørth, F. Blasi, and J. Johnsen 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583–1592.
  • O’Hagan, R. C., and J. Hassell 1998. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene 16:301–310.
  • O’Hagan, R. C., R. G. Tozer, M. Symons, F. McCormick, and J. Hassell 1996. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13:1323–1333.
  • Pages, G., P. Lenormand, G. L’Allemain, J. C. Chambard, S. Meloche, and J. Pouyssegur 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319–8323.
  • Reimold, A. M., M. J. Grusby, B. Kosaras, J. W. Fries, R. Mori, S. Maniwa, I. M. Clauss, T. Collins, R. L. Sidman, M. J. Glimcher, and J. Glimcher 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379:262–265.
  • Rørth, P., C. Nerlov, F. Blasi, and J. Johnsen 1990. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol ester. Nucleic Acids Res. 18:5009–5017.
  • Sambrook, J., E. F. Fritsch, T. Maniatis 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Stacey, K. J., L. F. Fowles, M. S. Colman, M. C. Ostrowski, and J. Hume 1995. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol. Cell. Biol. 15:3430–3441.
  • Vallone, D., S. Battista, G. M. Pierantoni, M. Fedele, L. Casalino, M. Santoro, G. Viglietto, A. Fusco, and J. Verde 1997. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16:5310–5321.
  • Verde, P., S. Boast, A. Franze, F. Robbiati, and J. Blasi 1988. An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 16:10699–10716.
  • Wasylyk, C., A. P. Bradford, A. Gutierrez-Hartmann, and J. Wasylyk 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899–913.
  • Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and J. Davis 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403–407.
  • Yamamoto, H., M. L. Flannery, S. Kupriyanov, J. Pearce, S. R. McKercher, G. W. Henkel, R. A. Maki, Z. Werb, and J. Oshima 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315–1326.
  • Yang, B.-S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and J. Ostrowski 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538–547.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.